A new study from University of Copenhagen researchers explains how some multidrug-resistant bacteria are able to survive lethal doses of antibiotics through a hibernation-like defense mechanism.
As multidrug-resistant bacterial pathogens continue to vex healthcare settings around the world, researchers work to understand the adaptations that make these superbugs so resistant. Now, in one new study, a team of scientists have identified how bacteria are able to evade the effects of antibiotic drugs.
According to the Centers for Disease Control and Prevention, more than 2 million people in the United States each year experience an infection with an antibiotic-resistant bacterial pathogen each year, and such infections go on to result in at least 23,000 deaths. Globally, the World Health Organization considers antibiotic resistance to be one of the biggest threats to our global health, food security, and development. While some pathogens have developed resistance to one or two antibiotic drugs, many bacteria have mutated or accumulated resistance genes to develop multidrug-resistance, making some infections untreatable with a number of first-line antibiotics. The most virulent bacteria today have become extensively drug-resistant or pan-drug resistant, and untreatable with even “last resort” medications.
In a number of studies, scientists have identified many of the mechanisms that drive antibiotic resistance, and now a new study from University of Copenhagen researchers explains how bacterial pathogens elude antibiotics. Their paper, published in the journal Science, sheds light on why some bacteria are able to cause recurrent and prolonged infections. While studying the molecular architecture of certain bacteria, the research team identified what they call “persister cells,” which help pathogens evade the damaging effects of antibiotic drugs, making some infections untreatable. These cells enable bacteria to essentially enter a dormant state, comparable to hibernation, regardless of whether or not a particular pathogen has any of the genes for antibiotic resistance.
“This amazing resilience is often due to hibernation in a physiological state called persistence where the bacteria are tolerant to multiple antibiotics and other stressors,” said study author Alexander Harms, PhD, in a recent press release from the University of Copenhagen. “Bacterial cells can switch into persistence by activating dedicated physiological programs that literally pull the plug of important cellular processes. Once they are persisters, the bacteria may sit through even long-lasting antibiotic therapy and can resuscitate to cause relapsing infections at any time after the treatment is abandoned.”
The formation of persister cells occur under conditions such as hostile host environments, say the authors, as well as in response to damage caused by sublethal concentrations of antibiotics. “Regularly growing bacteria differentiate into persister cells stochastically at a basal rate, but this phenotypic conversion can also be induced by environmental cues indicative of imminent threats for the bacteria,” note the authors in their paper, which goes on to note two major pathways of persister formation in Escherichia coli bacteria. “Consequently, persister formation is stimulated under conditions that favor the activation of these signaling pathways.”
While the discovery of persister cells offers a new direction for researchers studying antibiotic resistant bacteria and how to effectively fight them, the study notes that the ability of these cells to survive the lethal effects of antibiotics is still not entirely understood.